Singapore markets open in 35 minutes
Straits Times Index
3,110.73 +36.47 (+1.19%) S&P 500
4,604.37 +18.78 (+0.41%) Dow
36,247.87 +130.47 (+0.36%) Nasdaq
14,403.97 +63.97 (+0.45%) Bitcoin USD
43,743.33 -40.56 (-0.09%) CMC Crypto 200
914.81 +18.10 (+2.02%)
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 91.53B |
| Enterprise value | 84.32B |
| Trailing P/E | 23.96 |
| Forward P/E | 19.53 |
| PEG Ratio (5 yr expected) | 1.81 |
| Price/sales (ttm) | 7.30 |
| Price/book (mrq) | 3.68 |
| Enterprise value/revenue | 6.44 |
| Enterprise value/EBITDA | 17.36 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.14 |
| 52-week change 3 | 13.15% |
| S&P500 52-week change 3 | 15.38% |
| 52-week high 3 | 853.97 |
| 52-week low 3 | 668.00 |
| 50-day moving average 3 | 813.33 |
| 200-day moving average 3 | 786.56 |
Share statistics
| Avg vol (3-month) 3 | 454.25k |
| Avg vol (10-day) 3 | 536.66k |
| Shares outstanding 5 | 107.13M |
| Implied shares outstanding 6 | 108.95M |
| Float 8 | 101.75M |
| % held by insiders 1 | 2.55% |
| % held by institutions 1 | 89.31% |
| Shares short (14 Nov 2023) 4 | 1.4M |
| Short ratio (14 Nov 2023) 4 | 2.74 |
| Short % of float (14 Nov 2023) 4 | 1.53% |
| Short % of shares outstanding (14 Nov 2023) 4 | 1.28% |
| Shares short (prior month 12 Oct 2023) 4 | 1.37M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 30.47% |
| Operating margin (ttm) | 36.01% |
Management effectiveness
| Return on assets (ttm) | 9.21% |
| Return on equity (ttm) | 17.22% |
Income statement
| Revenue (ttm) | 13.1B |
| Revenue per share (ttm) | 122.63 |
| Quarterly revenue growth (yoy) | 14.50% |
| Gross profit (ttm) | 7.02B |
| EBITDA | 4.82B |
| Net income avi to common (ttm) | 3.99B |
| Diluted EPS (ttm) | 35.03 |
| Quarterly earnings growth (yoy) | -23.40% |
Balance sheet
| Total cash (mrq) | 9.91B |
| Total cash per share (mrq) | 93.22 |
| Total debt (mrq) | 2.7B |
| Total debt/equity (mrq) | 10.85% |
| Current ratio (mrq) | 5.18 |
| Book value per share (mrq) | 234.46 |
Cash flow statement
| Operating cash flow (ttm) | 5.22B |
| Levered free cash flow (ttm) | 3.53B |
© 2023 Yahoo. All rights reserved.